DD201790A5 - Verfahren zur herstellung von 3-aryl-5-isothiazolen - Google Patents
Verfahren zur herstellung von 3-aryl-5-isothiazolen Download PDFInfo
- Publication number
- DD201790A5 DD201790A5 DD81233487A DD23348781A DD201790A5 DD 201790 A5 DD201790 A5 DD 201790A5 DD 81233487 A DD81233487 A DD 81233487A DD 23348781 A DD23348781 A DD 23348781A DD 201790 A5 DD201790 A5 DD 201790A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- acid
- general formula
- amino
- ester
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/189,435 US4346094A (en) | 1980-09-22 | 1980-09-22 | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD201790A5 true DD201790A5 (de) | 1983-08-10 |
Family
ID=22697314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD81233487A DD201790A5 (de) | 1980-09-22 | 1981-09-22 | Verfahren zur herstellung von 3-aryl-5-isothiazolen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4346094A (enExample) |
| EP (1) | EP0048615B1 (enExample) |
| JP (1) | JPS5785379A (enExample) |
| KR (1) | KR830007597A (enExample) |
| AR (1) | AR229103A1 (enExample) |
| AT (1) | ATE7657T1 (enExample) |
| AU (1) | AU7551681A (enExample) |
| CS (1) | CS228536B2 (enExample) |
| DD (1) | DD201790A5 (enExample) |
| DE (1) | DE3163900D1 (enExample) |
| DK (1) | DK417981A (enExample) |
| ES (1) | ES8301225A1 (enExample) |
| FI (1) | FI812940L (enExample) |
| GB (1) | GB2084573B (enExample) |
| GR (1) | GR75046B (enExample) |
| IL (1) | IL63890A0 (enExample) |
| NO (1) | NO813208L (enExample) |
| PL (1) | PL130497B1 (enExample) |
| PT (1) | PT73711B (enExample) |
| RO (1) | RO82216A (enExample) |
| YU (1) | YU227181A (enExample) |
| ZA (1) | ZA816549B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428956A (en) | 1980-12-29 | 1984-01-31 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4431652A (en) * | 1980-12-29 | 1984-02-14 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4539328A (en) * | 1983-03-25 | 1985-09-03 | Fmc Corporation | Nematicidal isothiazole derivatives |
| US4620865A (en) * | 1983-11-07 | 1986-11-04 | Eli Lilly And Company | Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides |
| IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
| ZW21687A1 (en) * | 1986-12-12 | 1988-07-20 | Hoffmann La Roche | Triazine derivatives |
| JP2725886B2 (ja) * | 1990-11-30 | 1998-03-11 | 帝人株式会社 | ２―アリールチアゾール誘導体及びその医薬組成物 |
| US5294630A (en) * | 1992-07-07 | 1994-03-15 | Eli Lilly And Company | Treatment of inflammatory bowel disease |
| US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
| MY117352A (en) * | 1995-10-31 | 2004-06-30 | Ciba Sc Holding Ag | Oximesulfonic acid esters and the use thereof as latent sulfonic acids. |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| EP1044002A4 (en) | 1997-11-07 | 2003-05-02 | Univ Johns Hopkins | METHODS FOR THE TREATMENT OF HEART CONTRACTILITY |
| TW575792B (en) * | 1998-08-19 | 2004-02-11 | Ciba Sc Holding Ag | New unsaturated oxime derivatives and the use thereof as latent acids |
| SG78412A1 (en) | 1999-03-31 | 2001-02-20 | Ciba Sc Holding Ag | Oxime derivatives and the use thereof as latent acids |
| CA2474532A1 (en) | 2002-02-06 | 2003-08-14 | Peter Murer | Sulfonate derivatives and the use therof as latent acids |
| EP1783116B1 (en) * | 2004-08-27 | 2009-08-26 | Astellas Pharma Inc. | 2-phenylpyridine derivative |
| JPWO2006022375A1 (ja) * | 2004-08-27 | 2008-05-08 | アステラス製薬株式会社 | ２−フェニルチオフェン誘導体 |
| WO2007043457A1 (ja) | 2005-10-07 | 2007-04-19 | Astellas Pharma Inc. | トリアリールカルボン酸誘導体 |
| MX2008010646A (es) | 2006-02-24 | 2008-10-14 | Astellas Pharma Inc | Agente para tratar o prevenir ulcera digestiva. |
| GB2450975B (en) | 2007-07-12 | 2010-02-24 | Ciba Holding Inc | Yellow radiation curing inks |
| EP2668953A1 (en) * | 2008-05-22 | 2013-12-04 | Bristol-Myers Squibb Company | Pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate and/or an inhibitor of uric acid synthesis |
| PL2404908T3 (pl) | 2009-02-27 | 2014-12-31 | Teijin Ltd | Sposób wytwarzania podstawionej fenylem pochodnej heterocyklicznej przez sprzężenie z użyciem katalizatora metalu przejściowego |
| JP2012522084A (ja) | 2009-03-30 | 2012-09-20 | ビーエーエスエフ ソシエタス・ヨーロピア | Ｕｖ線量インジケータフィルム |
| RU2563459C2 (ru) | 2010-08-27 | 2015-09-20 | Тейдзин Фарма Лимитед | Способ получения фенилзамещенного гетероциклического производного посредством способа сочетания с использованием соединения палладия |
| US9310677B2 (en) | 2011-01-28 | 2016-04-12 | Basf | Polymerizable composition comprising an oxime sulfonate as thermal curing agent |
| RU2632884C2 (ru) * | 2013-03-29 | 2017-10-11 | Тейдзин Фарма Лимитед | Производное пиразола |
| WO2016030790A1 (en) | 2014-08-29 | 2016-03-03 | Basf Se | Oxime sulfonate derivatives |
| MX375374B (es) | 2015-04-29 | 2025-03-06 | Bsn Medical Gmbh | Dispositivo de baño médico. |
| CA2984044A1 (en) | 2015-04-29 | 2016-11-03 | Bsn Medical Gmbh | Steady-state no production via ph control |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1178604A (en) * | 1966-03-21 | 1970-01-21 | American Cyanamid Co | Novel Pyridinium Salts and Methods for Preparing Same |
| US3464999A (en) * | 1967-07-27 | 1969-09-02 | R & L Molecular Research Ltd | Thiadiazolylisothiazoles |
| GB1180268A (en) * | 1967-09-26 | 1970-02-04 | Ici Ltd | Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives |
| GB1192701A (en) * | 1968-03-22 | 1970-05-20 | Ici Ltd | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same |
| US3681498A (en) * | 1970-10-19 | 1972-08-01 | American Cyanamid Co | Isothiazolyl pyridinium salts as hypoglycemic agents |
-
1980
- 1980-09-22 US US06/189,435 patent/US4346094A/en not_active Expired - Lifetime
-
1981
- 1981-09-19 PL PL1981233103A patent/PL130497B1/pl unknown
- 1981-09-20 IL IL63890A patent/IL63890A0/xx unknown
- 1981-09-21 RO RO81105346A patent/RO82216A/ro unknown
- 1981-09-21 GR GR66108A patent/GR75046B/el unknown
- 1981-09-21 AT AT81304325T patent/ATE7657T1/de not_active IP Right Cessation
- 1981-09-21 FI FI812940A patent/FI812940L/fi not_active Application Discontinuation
- 1981-09-21 YU YU02271/81A patent/YU227181A/xx unknown
- 1981-09-21 PT PT73711A patent/PT73711B/pt unknown
- 1981-09-21 NO NO813208A patent/NO813208L/no unknown
- 1981-09-21 DE DE8181304325T patent/DE3163900D1/de not_active Expired
- 1981-09-21 AR AR286818A patent/AR229103A1/es active
- 1981-09-21 EP EP81304325A patent/EP0048615B1/en not_active Expired
- 1981-09-21 AU AU75516/81A patent/AU7551681A/en not_active Abandoned
- 1981-09-21 GB GB8128465A patent/GB2084573B/en not_active Expired
- 1981-09-21 ES ES505678A patent/ES8301225A1/es not_active Expired
- 1981-09-21 DK DK417981A patent/DK417981A/da not_active Application Discontinuation
- 1981-09-21 ZA ZA816549A patent/ZA816549B/xx unknown
- 1981-09-22 KR KR1019810003537A patent/KR830007597A/ko not_active Abandoned
- 1981-09-22 DD DD81233487A patent/DD201790A5/de unknown
- 1981-09-22 CS CS816978A patent/CS228536B2/cs unknown
- 1981-09-22 JP JP56150483A patent/JPS5785379A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR830007597A (ko) | 1983-11-04 |
| IL63890A0 (en) | 1981-12-31 |
| NO813208L (no) | 1982-03-23 |
| EP0048615A1 (en) | 1982-03-31 |
| PT73711B (en) | 1982-12-20 |
| ZA816549B (en) | 1983-04-27 |
| PT73711A (en) | 1981-10-01 |
| GB2084573B (en) | 1984-09-12 |
| AR229103A1 (es) | 1983-06-15 |
| PL130497B1 (en) | 1984-08-31 |
| FI812940A7 (fi) | 1982-03-23 |
| YU227181A (en) | 1983-10-31 |
| AU7551681A (en) | 1982-04-01 |
| GR75046B (enExample) | 1984-07-12 |
| ATE7657T1 (de) | 1984-06-15 |
| RO82216B (ro) | 1983-06-30 |
| US4346094A (en) | 1982-08-24 |
| ES505678A0 (es) | 1982-12-01 |
| JPS5785379A (en) | 1982-05-28 |
| PL233103A1 (enExample) | 1982-12-20 |
| EP0048615B1 (en) | 1984-05-30 |
| CS228536B2 (en) | 1984-05-14 |
| DK417981A (da) | 1982-03-23 |
| GB2084573A (en) | 1982-04-15 |
| DE3163900D1 (en) | 1984-07-05 |
| ES8301225A1 (es) | 1982-12-01 |
| FI812940L (fi) | 1982-03-23 |
| RO82216A (ro) | 1983-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD201790A5 (de) | Verfahren zur herstellung von 3-aryl-5-isothiazolen | |
| DE69207017T2 (de) | Benzamide | |
| DE69503769T2 (de) | Isoxazoline verbindung zur hemmung tnf-freigabe | |
| DD248588A5 (de) | Verfahren zur herstellung von hydroxy-und alkoxypyrimidinen | |
| DD218887A5 (de) | Verfahren zur herstellung von 1,4-dihydropyridinen | |
| DE19632549A1 (de) | Arylalkanoylpyridazine | |
| DE69222459T2 (de) | Thiazolidindionderivate, ihre Herstellung und Anwendung | |
| DD283402A5 (de) | Verfahren zur herstellung von 2-substituierten adenosinderivaten | |
| DE19830431A1 (de) | Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren | |
| DE2537070C2 (enExample) | ||
| DE10259244A1 (de) | N-(Indolethyl-)cycloamin-Verbindungen | |
| DD209446A5 (de) | Verfahren zur herstellung von neuen aromatischen verbindungen | |
| DE10235639A1 (de) | Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel | |
| CH646972A5 (en) | Process for the preparation of new 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids | |
| DD287495A5 (de) | Verfahren zur herstellung herterozyclischer stickstoffverbindungen | |
| DE3008904A1 (de) | 1-mercaptoacyldihydropyrazol-5-carbonsaeure-derivate und ihre salze mit basen, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von hypertonie | |
| DE1795822C2 (de) | Thiazolylalkancarbonsäuren, Verfahren zu ihrer Herstellung und antiphlogistische Zubereitung | |
| DE3216843C2 (de) | 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| US4255575A (en) | 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives | |
| DE69110217T2 (de) | Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen. | |
| US4645771A (en) | Tetrahydropyridine derivatives | |
| DE2322561A1 (de) | Trisubstituierte imidazole | |
| DD209194A5 (de) | Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten | |
| DE602005005967T2 (de) | Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament | |
| DD253616A5 (de) | Verfahren zur herstellung von neuen pleunromutilinderivaten |